alpha-amanitin has been researched along with Colonic Neoplasms in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Armbruester, V; Heyne, K; Mestres, P; Mueller, D; Roemer, K; Schmitt, K | 1 |
Anderl, J; Faulstich, H; Herr, I; Lüttgau, S; Moldenhauer, G; Salnikov, AV | 1 |
2 other study(ies) available for alpha-amanitin and Colonic Neoplasms
Article | Year |
---|---|
Resistance of mitochondrial p53 to dominant inhibition.
Topics: Alpha-Amanitin; Antineoplastic Agents; Apoptosis; Cell Proliferation; Colonic Neoplasms; Cyclin-Dependent Kinase Inhibitor p21; DNA-Binding Proteins; Etoposide; Fluorouracil; Gene Expression Regulation, Neoplastic; Genes, Dominant; HCT116 Cells; Humans; Mitochondria; Mutation; Nuclear Proteins; Promoter Regions, Genetic; Protein Binding; Time Factors; Transcriptional Activation; Tumor Protein p73; Tumor Suppressor Protein p53; Tumor Suppressor Proteins | 2008 |
Therapeutic potential of amanitin-conjugated anti-epithelial cell adhesion molecule monoclonal antibody against pancreatic carcinoma.
Topics: Alpha-Amanitin; Angiogenesis Inhibitors; Animals; Antibodies, Monoclonal; Antigens, Neoplasm; Antineoplastic Agents; Biomarkers, Tumor; Carcinoma; Cell Adhesion Molecules; Cell Line, Tumor; Cell Proliferation; Chimera; Colonic Neoplasms; Enzyme Inhibitors; Epithelial Cell Adhesion Molecule; Female; Flow Cytometry; Gene Expression Regulation, Neoplastic; Humans; Immunoconjugates; Immunohistochemistry; Liver; Mice; Mice, Inbred NOD; Mice, SCID; Pancreatic Neoplasms; Up-Regulation; Xenograft Model Antitumor Assays | 2012 |